Kyoto University Hospital will start clinical trials for Parkinson’s disease that transplants dopaminergic progenitors generated from induced pluripotent stem (iPS) cells.
About 5 million iPS cell-derived dopaminergic progenitors will be transplanted by stereotaxic brain surgery into the left and right sides of the patient’s putamen.
A 12mm diameter hole will be drilled on the patient’s skull, and stem cells will be injected using a specialized device.
Patient aged between 50 and 69 will participate in the trial and their progress will be monitored for two years.
About 10 million people in the world have Parkinson’s. About one million people in the USA have Parkinson’s.